Bogle Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-124,515
Closed -$4.66M 319
2017
Q3
$4.66M Buy
124,515
+68,744
+123% +$2.34M 0.32% 114
2017
Q2
$1.74M Buy
55,771
+12,667
+29% +$366K 0.13% 159
2017
Q1
$1.06M Sell
43,104
-57,377
-57% -$1.35M 0.07% 216
2016
Q4
$2.55M Buy
100,481
+27,316
+37% +$606K 0.18% 154
2016
Q3
$1.45M Buy
+73,165
New +$1.28M 0.1% 196
2016
Q2
Sell
-81,926
Closed -$1.27M 434
2016
Q1
$1.27M Sell
81,926
-10,876
-12% -$156K 0.08% 238
2015
Q4
$1.6M Buy
92,802
+25,685
+38% +$372K 0.12% 218
2015
Q3
$818K Buy
+67,117
New +$861K 0.06% 277

Other funds holding LMAT

Bogle Investment Management's LMAT Position: Q4 2017 in Review

Bogle Investment Management sold out of LeMaitre Vascular (LMAT) in Q4 2017, closing a stake of 124,515 shares — an estimated $4.66M sold.

Bogle Investment Management first reported a position in LMAT in Q3 2015 and held it in 8 quarters. The position peaked at $4.66M in Q3 2017. 142 funds tracked by Wall St. Rank hold LMAT as of Q4 2017.

  • Bogle Investment Management reported no remaining LeMaitre Vascular position as of Q4 2017 after selling out during the quarter.
  • Bogle Investment Management sold 124,515 LeMaitre Vascular shares in Q4 2017, an estimated $4.66M.
  • Bogle Investment Management first reported a position in LeMaitre Vascular in Q3 2015 and held it in 8 quarters.
  • Bogle Investment Management's LeMaitre Vascular position peaked at $4.66M in Q3 2017.
  • 142 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2017.

Based on Bogle Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.